abstract |
The present invention provides a T cell receptor (TCR) capable of specifically binding a short peptide KWVESIFLIF derived from an AFP antigen, the antigen short peptide KWVESIFLIF can form a complex with HLA A2402 and be presented together to a cell surface. The present invention further provides a nucleic acid molecule encoding the TCR and a vector comprising the nucleic acid molecule. In addition, the present invention further provides a cell transducing the TCR. |